Sun Life Financial Inc. Common Stock vs Synopsys, Inc. — how do they compare? Sun Life Financial Inc. Common Stock trades at $77.62 (market cap $43.44B), while Synopsys, Inc. trades at $473.13 (market cap $91.97B). The key difference: Synopsys, Inc. is far larger — about 2.1× Sun Life Financial Inc. Common Stock's market cap, and Sun Life Financial Inc. Common Stock pays a 3.47% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sun Life Financial Inc. Common Stock for 0 Days and Synopsys, Inc. for 72 Days on average.
| SLF | SNPS | |
|---|---|---|
Market Cap | $43.44B | $91.97B |
Volume | 333,821 | 3,203,530 |
Sector | Financials | Technology |
52-Week High | $84.07 | $534.56 |
52-Week Low | $57.60 | $367.70 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $45.17B | $99.21B |
Dividend Yield | 3.47% | — |
Signals from Pluang's Aura AI — not financial advice
Sun Life Financial (SLF) trades at $77.87, up 0.69% on the day, reflecting steady momentum. The stock shows consistent earnings beats in recent quarters, with Q3 2026 results pending. Financial health is solid, with a P/E of 18.82 and robust cash flow projections for 2026. Recent strategic moves include expanding disability benefits and forming a reinsurance partnership, signaling growth initiatives.
The outlook for SLF is cautiously optimistic, supported by earnings strength and strategic expansions. Key risks include competitive pressures and macroeconomic volatility. Analyst sentiment is mixed, with a majority hold rating, suggesting potential stability but limited near-term upside. Investors should weigh solid fundamentals against sector headwinds.
Synopsys (SNPS) trades at $494.51, down 1.59% on the day, but maintains a strong bullish technical trend with recent price action supported by positive investor sentiment. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $3.91 exceeding the $3.67 estimate. Recent partnerships with OpenAI and Amazon Web Services, including a $1 billion deal, have driven optimism and a 13% stock surge, highlighting its strategic positioning in AI-driven chip design.
The outlook for SNPS is positive, supported by robust analyst consensus, with 28 of 30 analysts rating it a Buy and a consensus price target of $575.93 implying significant upside. Key risks include high valuation multiples, such as a P/E of 86.3, and integration challenges from the Ansys acquisition. Revenue growth is projected to accelerate, with 2026 guidance surpassing expectations, though margin compression remains a watch point.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Sun Life Financial Inc. is a Canada-based financial services company providing insurance, wealth and asset management, and health solutions for individuals and institutions. Its products span life, health, and disability insurance along with mutual funds and pension asset management, through operations in Canada, US, the United Kingdom, Ireland, and across Asia.
Read more on SLF →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →